Skin and Joints Podcast

🎙️ HS & Biosimilars: The Switch Pitch — Part 3 Final drop, biggest pearls. 💎 Is HS is the new acne? How can we treat early, treat seriously, and help prevent long-term scarring—physical and emotional? In Part 3 of our real-world HS conversation, Skin and Joints Podcast F aculty Dr. Lauren Lam and Dr. Marni Wiseman bring the discussion home with practical, clinic-ready insights for dermatologists...

🎙️ PART 2:   HS & Biosimilars: The Switch Pitch — Real-World Pearls from the Clinic 💉🔥🧴 In Part 2 of our HS and biosimilars conversation, we’re getting practical — very practical. 🎧🩺 Faculty Dr. Lauren Lam and Dr. Marni Wiseman join the Skin and Joints Podcast to unpack what really matters when biosimilars move from policy, paperwork, and prescribing forms… into the real lives of patients wit...

🎙️🇨🇦🇺🇸. Hands On, Gloves Off: Cross-Border Talk on Atopic Hand Eczema We’re coming to you from the heart of Music City, Nashville 🎸 — but don’t worry, this Cross-Border Talk is not about trade, tariffs, or hockey rivalries. This time, it’s all hands on deck. ✋🇨🇦🇺🇸 In this episode of the Skin and Joints Podcast from RAD 2026, our Cross-Border Dermatologist Faculty Dr. Raj Chovatiya from the U.S....

🎙️ PART 1:   Real-World Biosimilar Care in HS with Dr. Lauren Lam and Dr. Marni Wiseman HS has officially entered the Skin and Joints chat — and it did not come quietly. In this special Part 1 episode, we welcome back two Skin and Joints Podcast Faculty favourites, dermatologists Dr. Lauren Lam and Dr. Marni Wiseman, for a practical, candid, and refreshingly real-world conversation on hidradenitis...

🎙️The Great Dose Debate: Escalate, De-escalate, or Hold Steady? In this final episode of our AAD 2026 atopic dermatitis post-game poster series, we’re joined by dermatologist Dr. Julien Ringuet from Quebec City for a practical, no-fluff breakdown of the JADE REAL analysis — and what flexible abrocitinib dosing may actually mean when Monday morning clinic rolls around. Because in real life, patient...

From Clearer Skin to Better Sleep: MDA and Redefining Success in Atopic Dermatitis 🎙️ Are We Treating Eczema… or Just Admiring Better Scores? Minimal Disease Activity in Atopic Dermatitis In this rapid-fire AAD poster recap, dermatologist Dr. Julien Ringuet joins the Skin and Joints podcast to unpack a big idea with a small acronym: MDA — Minimal Disease Activity . Borrowed from the rheumatology p...

JAKs, Flares & Rescue Plans:  The Art of the Atopic Dermatitis Dose-Dow n 🎙️ In this rapid-fire post-AAD recap, dermatologist Faculty Dr. Julien Ringuet joins the Skin and Joints Podcast to tackle a question that comes up all the time in real-world atopic dermatitis care: once a patient is doing well, can we safely step down therapy without sending their skin into rebellion? Using newly presented...

Skin, joints, and staying power—because in psoriasis, “getting clear” is only half the story. In this episode of the Skin and Joints Podcast 🎧 , dermatologist Dr. Chih-ho Hong  and rheumatologist Dr. May Kazem  team up again for a lively, multidisciplinary deep dive into new 24-month real-world data from PSoHO 📊 , an international prospective observational study of biologic-treated patients with...

🎙️ 💡 When Skin and Joints Actually Mean… Skin AND Joints In this episode of the Skin and Joints Podcast , we bring together two expert voices — dermatologist Dr. Chih-ho Hong and rheumatologist Dr. May Kazem — for a true cross-specialty conversation on psoriatic arthritis care.  The focus? 🔍 The recent PRO-SPIRIT 12-month real-world study exploring the comparative effectiveness and persistence b...

🎙️✨ Melinda Knows Best at AAD Denver: Hands Down, Chronic Hand Eczema Is Getting a New Playbook 🖐️ Live from AAD 2026 in Denver 🏔️, a podcast favorite, Melinda Knows Best returns with Dr. Melinda Gooderham for a true post-game analysis🏀 of new chronic hand eczema data — and yes, this one is all about helping hands get back to doing what hands do best: opening jars 🥜, buttoning shirts 👔, holdin...

🎙️✨ Isotretinoin + Clascoterone: Acne’s New Power Couple? When acne gets severe, isotretinoin usually enters the chat as the big gun.💥 But what happens when you pair it with topical clascoterone — the anti-androgen sidekick targeting the sebaceous gland from another angle? In this episode, we break down new real-world data from a multi-centre retrospective study comparing oral isotretinoin monot...

🎙️✨ New Acne Data Just Dropped — and We’re Bringing the Post-Game Analysis from AAD 2026! 🏀 Live from Denver — the Mile High City — the Skin and Joints Podcast is breaking down new 52-week real-world acne data exploring the impact of clascoterone 1% on sebum reduction, acne improvement, tolerability, and what it actually means in day-to-day dermatology practice. Because let’s be honest: in acne...

🎙️ Age, Risk, and the JAK Factor: A 6-Year Safety Deep Dive- Part 2   Guests: Dr. Marissa Joseph and Dr. Fiona Lovegrove Location: 📍 AAD 2026 We’re back with Part 2 of our atopic dermatitis double-header with Dr. Marissa Joseph and Dr. Fiona Lovegrove from AAD 2026 in Denver —and this time, we’re getting into the data that always enters the chat when JAK inhibitors in Atopic Dermatitis are mentio...

🎙️ If They Get There, Do They Stay There? A 140-Week AD Data Dive — Part 1 of a 2-Part Double Header   Guests: Dr. Marissa Joseph and Dr. Fiona Lovegrove Location: 📍 AAD 2026 We came to Denver for AAD 2026, adjusted to the altitude, caught our breath — barely — and dove straight into the data. In Part 1 of this two-part atopic dermatitis double header, Dr. Marissa Joseph and Dr. Fiona Lovegrove j...

🎙️   World Psoriasis Day Special    This special World Psoriasis Day episode of The Skin and Joints Podcast shines a light on the evolving psoriasis journey—from the first plaque to total skin clearance. Dermatologist Dr. Jessica Asgarpour , now back in her sunny hometown of Calgary, joins us for an honest, hopeful conversation about how far psoriasis care has come—and where it’s headed next. From...

Acne in Paris: Croissants, Comedones & Cutting-Edge Care at EADV 2025 Guests: Dr. Chloe Ward & Dr. Natalie Cunningham Location: 📍 EADV 2025, Paris 🇫🇷 From café chatter to late-breaker abstracts, this fresh field report stitches together breaking new data and what matters for acne care today.  Our two Canadian derm Faculty dynamos, Dr. Chloe Ward and Dr. Natalie Cunningham , join us live from EADV...

Acne in Paris: Croissants, Comedones & Cutting-Edge Care at EADV 2025 Guests: Dr. Chloe Ward & Dr. Natalie Cunningham Location: 📍 EADV 2025, Paris 🇫🇷 From café chatter to late-breaker abstracts, this fresh field report stitches together breaking new data and what matters for acne care today.  Our two Canadian derm Faculty dynamos, Dr. Chloe Ward and Dr. Natalie Cunningham , join us live from EADV...

Paris Pop-Up: Hands Down the Most Fun You’ll Have Learning About Chronic Hand Eczema Late Breaker Edition Chronic Hand Eczema in Focus: DELTA-Teen efficacy & pooled safety of topical pan-JAK  Episode Tasting Menu 🍽️: Jet-lag ✈️, steak-frites , and NEW science : we unpack fresh adolescent data for a topical pan-JAK cream in chronic hand eczema (CHE) and a pooled safety package that’s so uneventful...

  PART 2 — Mix, Match & Don’t Backlash: Barrier-first acne care—does clascoterone deliver? 🧱✨ 🍿 Dermatologist Faculty Dr. Christina + Dr. Angela Law are back, and this time we connect the dots between skin barrier 🛡️ , TEWL , and real-world adherence. In PART 2, we stress-test the skin-barrier data behind clascoterone and translate it into clinic-ready moves. We’ll appraise the evidence (think...

🎙️  Our PsO Playbook: Brothers on the Fairway, Biologics Experts in the Clinic ⛳️🧬✨ What happens when two Ontario derms  swap the golf course for the Skin and Joints studio?  You get a rapid-fire, real-world deep dive into bimekizumab for plaque psoriasis—complete with candid golf confessions, myth-busting on intra-class switching, and a candidiasis reality check you can actually use. Dr. Ron V...

🎙️  Before the Referral to Dr. Abdulla: Filling Your Acne 🛒 ‘Shopping Cart’—Rapid-Fire Ingredients & Real-World Care Considerations (Part 3 of 3) Episode description While your patient sits on a six-month wait-list for dermatology, their acne isn’t taking a holiday.  In the finale of our ingredient deep-dive mini-series, Dr. Sonya Abdulla add to the bulging cart: neo-glucosamine 🧴, glycerin 💧,...

🎙️ Skin & Joints Podcast — Acne Aisle Adventure with Dr. Sonya Abdulla (Part 2 of 3) 🎙️ Dr. Sonya Abdulla is back at the mic, and her shopping cart is starting to look like it needs four-wheel drive. This second instalment rockets from benzoyl-peroxide to sulfur’s glow-up (no more rotten-egg vibes), detours into niacinamide’s barrier-boosting superpowers, and lands on why retinol deserves a nightl...

  🛒 Skin & Joints Podcast — Acne Aisle Adventure (Part 1 of 3) 🛒 Ready to turn the drug‑store shelf into your acne‑fighting playground? In this episode host‑with‑the‑most Erin Sahota tags in Toronto derm dynamo Dr. Sonia Abdulla for a cart‑cramming romp through OTC land. From prairie roots to downtown Toronto chic, Dr. A spills secrets on why salicylic acid is the Beyoncé of beta‑hydroxy acids,...

🎙️ Part 2 – Safety First 🛡️✨ Still basking in Orlando sun, the crew zooms from efficacy fireworks to the serious stuff : a massive 2,500-patient-year integrated safety update on abrocitinib . Dr. Loo runs the numbers so you don’t have to: Four-and-a-half years of data, ~1,600 patients, ages 18–39 📊 No signal for VTE, MACE, or new malignancies despite the boxed-warning hype 🚫❤️‍🩹 Main watch-out...

🎙️PART 1: From Dupilumab to Abrocitinib🩺✨ Sun-kissed Orlando sets the stage as we talk all things eczema from dupilumab to abrocitinib—after squeezing in a little Disney magic, of course.  Listen to fresh poster data on switching stubborn AD patients from dupilumab to abrocitinib and debate whether to hit hard with 200 mg or start slow at 100 mg . Rapid EASI-90 gains, itch-free nights, and a “fl...